Netherlands· NL-da412a8ac86b

Tasmar 100 mg , filmomhulde tabletten

A tolcapone product containing tolcapon, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 15 of our 19 countries.

ATC N04BX01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tolcaponAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tolcapone is registered in 15 of 19 countries.

Countries holding a registration under ATC N04BX01 (tolcapone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search tolcapone products by name

Tolcapone · ATC N04BX01

15 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tolcapone costs, country by country.

Normalised to the WHO defined daily dose (0.45 g), the median price runs from $6.12 in France to $9.92 in Switzerland — a ×1.6 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Tolcapone · price per daily dose (0.45 g)

USD · FX 28 Sept 2026

CH Switzerland$9.92
IT Italy$8.47
FR France$6.12

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TOLCAPON
Manufacturer: Viatris Healthcare Limited
Country: Netherlands (NL)
ATC code: N04BX01
ATC class: Tolcapone
Defined daily dose: 0.45 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/97/044

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

88 interactions on record for tolcapone.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tolcapone against other medicines How interaction checks work

Tolcapone · interactions on record

88 records

6 severe
74 moderate
2 minor
6 info

Most severe, free to view

ProcarbazineL01XB01severe
LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tolcapone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tolcapone products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

Germany · Tolcapon Neuraxpharm
Iceland · Tasmar
Liechtenstein · Tasmar
Norway · Tasmar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d25685a8-c412-485b-8ea8-82c5d73104ca
GET /v1/drugs/d25685a8-c412-485b-8ea8-82c5d73104ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tasmar-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Tolcapone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70305",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "ETHYLCELLULOSE (E 462)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TOLCAPON"
  ],
  "leaflet_url": null,
  "authorised_at": "1997/08/27",
  "procedure_number": "EMEA/H/C/000132",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/97/044",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about tolcapone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console